XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (9,270) $ (8,016) $ (7,987) $ (10,219) $ (17,286) $ (18,206)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         75 56  
Noncash lease expense relating to operating lease right-of-use assets         103 727  
Gain on termination of operating lease, net         (1,612) 0 $ (5,954)
Common stock purchase agreement costs         306 0  
Debt issuance costs 36   0   2,020 0  
Inventory write-downs, net of scrapped inventory         24 112  
Change in fair value of convertible note and warrant liabilities 593   15   (87) 13  
Stock-based compensation         3,661 4,754  
Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest         (157) (428)  
Expected credit losses, net of write-off         2 34  
Changes in operating assets and liabilities:              
Accounts receivable, net         (18) 90  
Inventories, current and noncurrent, net         (114) 89  
Prepaid and other current assets         84 724  
Other noncurrent assets         134 171  
Accounts payable         1,761 108  
Accrued expenses and other current liabilities         (1,522) (1,402)  
Operating lease liabilities         (1,532) (799)  
Contract liabilities         0 74  
Other noncurrent liabilities         0 (358)  
Net cash (used in) operating activities         (14,158) (14,241)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Purchases of property and equipment         (14) (234)  
Purchases of marketable securities         (14,303) (15,173)  
Proceeds from redemptions and maturities of marketable securities         9,631 18,400  
Net cash (used in) provided by investing activities         (4,686) 2,993  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from exercise of stock options         0 134  
Proceeds from issuance of convertible note         2,950 146  
Payments for convertible note redemptions         (750) 0  
Transaction costs related to issuance of convertible note         (608) 0  
Proceeds from issuance of common stock under Common Stock Purchase Agreements         10,076 5,560  
Stock issuance costs related to Common Stock Purchase Agreements         (404) (288)  
Taxes paid related to the net share settlement of equity awards         (364) (47)  
Proceeds from issuance of common stock through the Employee Stock Purchase Plan         52 26  
Net cash provided by financing activities         10,952 5,531  
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH         (7,892) (5,717)  
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period   $ 10,266   $ 19,082 10,266 19,082 19,082
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period $ 2,374   $ 13,365   2,374 13,365 $ 10,266
SUPPLEMENTAL CASH FLOW INFORMATION:              
Cash paid for income taxes, net of refund         21 1  
Cash paid for interest         0 0  
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:              
Noncash debt issuance costs         1,362 0  
Stock issuance costs included in accounts payable and accrued liabilities         213 128  
Debt issuance costs included in accounts payable and accrued liabilities         50 0  
Purchases of property and equipment included in accounts payable and accrued liabilities         $ 5